BCDA
BioCardia, Inc.
BioCardia, Inc. insider trading
BioCardia, Inc. is on this site because an insider bought its stock on the open market in the last 30 days. Every open-market purchase and sale its officers, directors and 10% owners filed in that time is listed below, each linked to the original Form 4.
From SEC filings · last 30 days
Recent BCDA insider transactions
The filing store could not be read just now — this page tries again on its next refresh. The filings themselves are on SEC EDGAR.
SEC Form 4 data, Q3 2024 to Q2 2026
BCDA insider trading by quarter
Between Jul 01, 2024 and Jun 30, 2026, 7 insiders traded BCDA on the open market: 59 purchases worth $2M and 1 sale worth $6.5K. In the last four quarters alone: 26 purchases ($1.1M) and 0 sales, by 3 insiders.
| Quarter | Bought | Sold | Insiders |
|---|---|---|---|
| Q2 2026 | +$128.7K12 buys | — | |
| Q1 2026 | +$8K5 buys | — | |
| Q4 2025 | +$1.4K2 buys | — | |
| Q3 2025 | +$923.2K7 buys | — | |
| Q2 2025 | +$802.1K22 buys | — | |
| Q1 2025 | +$94.8K7 buys | — | |
| Q4 2024 | +$5.1K3 buys | −$6.5K1 sale | |
| Q3 2024 | +$9151 buy | — |
- Largest purchase
- +$498K of BCDA by Stertzer Simon H (Director) on Sep 19, 2025.
- Largest sale
- −$6.5K of BCDA by Gillis Edward M (Senior Vice President, Devices) on Dec 20, 2024.
Open-market transactions through Jun 30, 2026most recent first
Stertzer Simon H
Director
+$39K
Jun 23, 2026
39,000 sh · $1.00
Stertzer Simon H
Director
+$64.6K
Jun 22, 2026
70,200 sh · $0.92
Altman Peter
President and CEO · Director
+$768
Jun 18, 2026
800 sh · $0.96
Altman Peter
President and CEO · Director
+$1.3K
Jun 17, 2026
1,500 sh · $0.85
Altman Peter
President and CEO · Director
+$4.3K
Jun 09, 2026
5,000 sh · $0.85
Altman Peter
President and CEO · Director
+$1.4K
May 20, 2026
1,500 sh · $0.92
Altman Peter
President and CEO · Director
+$190
May 19, 2026
200 sh · $0.95
Altman Peter
President and CEO · Director
+$5.2K
May 18, 2026
5,700 sh · $0.92
Altman Peter
President and CEO · Director
+$5.2K
May 15, 2026
5,100 sh · $1.02
Altman Peter
President and CEO · Director
+$5.6K
Apr 29, 2026
5,000 sh · $1.11
Altman Peter
President and CEO · Director
+$492
Apr 21, 2026
400 sh · $1.23
Altman Peter
President and CEO · Director
+$738
Apr 20, 2026
600 sh · $1.23
Altman Peter
President and CEO · Director
+$366
Mar 25, 2026
300 sh · $1.22
Altman Peter
President and CEO · Director
+$744
Mar 24, 2026
600 sh · $1.24
Altman Peter
President and CEO · Director
+$5.7K
Feb 04, 2026
5,000 sh · $1.13
| Date | Insider | Shares | Price | Value |
|---|---|---|---|---|
| Jun 23, 2026 | Stertzer Simon HDirector | 39,000 | $1.00 | +$39K |
| Jun 22, 2026 | Stertzer Simon HDirector | 70,200 | $0.92 | +$64.6K |
| Jun 18, 2026 | Altman PeterPresident and CEO · Director | 800 | $0.96 | +$768 |
| Jun 17, 2026 | Altman PeterPresident and CEO · Director | 1,500 | $0.85 | +$1.3K |
| Jun 09, 2026 | Altman PeterPresident and CEO · Director | 5,000 | $0.85 | +$4.3K |
| May 20, 2026 | Altman PeterPresident and CEO · Director | 1,500 | $0.92 | +$1.4K |
| May 19, 2026 | Altman PeterPresident and CEO · Director | 200 | $0.95 | +$190 |
| May 18, 2026 | Altman PeterPresident and CEO · Director | 5,700 | $0.92 | +$5.2K |
| May 15, 2026 | Altman PeterPresident and CEO · Director | 5,100 | $1.02 | +$5.2K |
| Apr 29, 2026 | Altman PeterPresident and CEO · Director | 5,000 | $1.11 | +$5.6K |
| Apr 21, 2026 | Altman PeterPresident and CEO · Director | 400 | $1.23 | +$492 |
| Apr 20, 2026 | Altman PeterPresident and CEO · Director | 600 | $1.23 | +$738 |
| Mar 25, 2026 | Altman PeterPresident and CEO · Director | 300 | $1.22 | +$366 |
| Mar 24, 2026 | Altman PeterPresident and CEO · Director | 600 | $1.24 | +$744 |
| Feb 04, 2026 | Altman PeterPresident and CEO · Director | 5,000 | $1.13 | +$5.7K |
From SEC's quarterly Form 3, 4 and 5 data sets: code P purchases and code S sales of common stock, by the date the trade happened. Where a fund and the people who control it each report the same block, it is counted once. Trades made in the last days of Q2 2026 but filed after it closed arrive with SEC's next quarterly release.
Don't check BCDA — let it ping you
Watch every insider filing the minute it clears the SEC
The live dashboard reads every Form 4 as it lands and puts it in plain English — open-market buys, cluster buys where several insiders move at once, and the sales executives chose to make rather than scheduled. Free to open; Pro adds alerts, watchlists and each buyer's track record.
BioCardia, Inc. is outside the 777 companies InsiderPulse scans continuously. This page is built from the filings on the live tape and stays up while its insiders are buying. Monitoring, not advice.
Other companies insiders are buying now
Questions
- How much BCDA stock have insiders bought and sold in the last two years?
- Between Jul 01, 2024 and Jun 30, 2026, 7 BioCardia, Inc. insiders made 59 open-market purchases worth $2M and 1 sale worth $6.5K. In the four quarters to Jun 30, 2026: 26 purchases ($1.1M) and no sales. The largest purchase was Stertzer Simon H buying $498K on Sep 19, 2025. The largest sale was Gillis Edward M selling $6.5K on Dec 20, 2024.
- Where does BCDA insider trading data come from?
- From the Form 4 filings BioCardia, Inc.'s officers, directors and 10% owners must send the SEC within two business days of a trade. Each row on this page links to its original filing on SEC EDGAR. Share grants and option exercises are kept apart from open-market purchases and sales, because only the latter cost the insider their own money.
Get the free Insider Brief
Each weekday evening: the day's biggest open-market insider buys, cluster formations and 10b5-1 plan breaks — in plain English, with grants and routine vesting stripped out. Honest about what the data can and cannot say.